Your browser doesn't support javascript.
loading
Overcoming the challenges of drug development in platinum-resistant ovarian cancer.
Eskander, Ramez N; Moore, Kathleen N; Monk, Bradley J; Herzog, Thomas J; Annunziata, Christina M; O'Malley, David M; Coleman, Robert L.
Affiliation
  • Eskander RN; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Rebecca and John Moores Cancer Center, University of California San Diego Health, San Diego, CA, United States.
  • Moore KN; Gynecologic Oncology, Stephenson Cancer Center, The University of Oklahoma College of Medicine, Oklahoma, OK, United States.
  • Monk BJ; Gynecologic Oncology, HonorHealth Research Institute, University of Arizona College of Medicine, Creighton University School of Medicine, Phoenix, AZ, United States.
  • Herzog TJ; Obstetrics and Gynecology, University of Cincinnati Cancer Center, Cincinnati, OH, United States.
  • Annunziata CM; Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.
  • O'Malley DM; Division of Gynecologic Oncology, The Ohio State University and The James Comprehensive Cancer Center, Columbus, OH, United States.
  • Coleman RL; Gynecologic Oncology, US Oncology Research, Texas Oncology, The Woodlands, TX, United States.
Front Oncol ; 13: 1258228, 2023.
Article in En | MEDLINE | ID: mdl-37916177
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza